Our approach to creating phase-transitioning materials that facilitate therapies to recover lost functions by diseases. Starting with polymer synthesis, we design materials that form structures capable of undergoing stimuli-responsive phase transitions. These hydrogels are injected directly into damaged tissues, adapting to the environment and promoting therapies for conditions such as cancer, arthritis, stroke, spinal cord injury, and ocular diseases. Our focus is on developing biomaterials that integrate seamlessly into the body and actively contribute to healing. 

Our work on polymer-based nanoparticles and nano-gel-nano systems for targeted drug delivery. These materials are synthesized with precision to deliver drugs to treat diseases due to promoting cell proliferation, cell death, differentiation, and functionalization on purpose. By engineering these nanomaterials, we aim to tackle diseases at the cellular level, offering innovative solutions for patient-tailored therapy. This research bridges the gap between nanotechnology and advanced therapies. 

Our research on advanced coating systems for implantable devices. We focus on stimuli-responsive actuators that adapt to environmental triggers, such as temperature and pH, enhancing device functionality. Additionally, our medical device coating systems improve biocompatibility, waterproofing, and adhesion while enabling biodegradation when necessary. These coatings ensure that implantable devices integrate better with surrounding tissues, minimizing adverse reactions and maximizing therapeutic outcomes.